Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,085
archived clinical trials in
Cervical Cancer

Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project (Prevention Care Manager 3 Project)
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project
Status: Enrolling
Updated:  7/25/2016
Urban Health Plan
mi
from
Bronx, NY
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project (Prevention Care Manager 3 Project)
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project
Status: Enrolling
Updated: 7/25/2016
Urban Health Plan
mi
from
Bronx, NY
Click here to add this to my saved trials
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project (Prevention Care Manager 3 Project)
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project
Status: Enrolling
Updated:  7/25/2016
Montefiore Family Care Center
mi
from
Bronx, NY
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project (Prevention Care Manager 3 Project)
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project
Status: Enrolling
Updated: 7/25/2016
Montefiore Family Care Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project (Prevention Care Manager 3 Project)
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project
Status: Enrolling
Updated:  7/25/2016
Good Shepherd Service
mi
from
Bronx, NY
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project (Prevention Care Manager 3 Project)
Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women Project
Status: Enrolling
Updated: 7/25/2016
Good Shepherd Service
mi
from
Bronx, NY
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Phoenix, AZ
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Indianapolis, IN
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Louisville, KY
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Baltimore, MD
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Boston, MA
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
New York, NY
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Seattle, WA
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Milwaukee, WI
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Newport Beach, CA
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Orange, CA
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Palo Alto, CA
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Palo Alto, CA
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
San Francisco, CA
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Denver, CO
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
New Haven, CT
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Boca Raton, FL
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Boca Raton, FL
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Orlando, FL
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Hinsdale, IL
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Hinsdale, IL
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Scarborough, ME
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Scarborough, ME
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Voorhees, NJ
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Voorhees, NJ
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Durham, NC
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Abington, PA
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Abington, PA
Click here to add this to my saved trials
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function
Immediate Vaginal Reconstruction Following Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function
Status: Enrolling
Updated:  8/9/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function
Immediate Vaginal Reconstruction Following Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function
Status: Enrolling
Updated: 8/9/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated:  11/29/2016
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated: 11/29/2016
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated:  11/29/2016
Fox Chase Cancer Center - Philadelphia
mi
from
Philadelphia, PA
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated: 11/29/2016
Fox Chase Cancer Center - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
High-dose Periop Statins for Prevention of DVT
High-dose Statin Therapy in the Perioperative Period and DVT Prevention.
Status: Enrolling
Updated:  11/30/2016
Yale-New Haven Hospital
mi
from
New Haven, CT
High-dose Periop Statins for Prevention of DVT
High-dose Statin Therapy in the Perioperative Period and DVT Prevention.
Status: Enrolling
Updated: 11/30/2016
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Pillars4Life Trial
Pillars4Life Randomized Control Trial
Status: Enrolling
Updated:  12/6/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Pillars4Life Trial
Pillars4Life Randomized Control Trial
Status: Enrolling
Updated: 12/6/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
Status: Enrolling
Updated:  12/14/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
Status: Enrolling
Updated: 12/14/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
Status: Enrolling
Updated:  12/14/2016
Lyndon B. Johnson General Hospital
mi
from
Houston, TX
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
Status: Enrolling
Updated: 12/14/2016
Lyndon B. Johnson General Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery
A Phase I Study Using Abdominal Radiotherapy as a Cisplatin Chemosensitizer for Optimally Debulked Stage III/IV Carcinoma of the Endometrium
Status: Enrolling
Updated:  12/14/2016
University of Miami Sylvester Comprehensive Cancer Center - Miami
mi
from
Miami, FL
Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery
A Phase I Study Using Abdominal Radiotherapy as a Cisplatin Chemosensitizer for Optimally Debulked Stage III/IV Carcinoma of the Endometrium
Status: Enrolling
Updated: 12/14/2016
University of Miami Sylvester Comprehensive Cancer Center - Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer
A Phase I/II Study of Docetaxel as a Radiosensitizer for Locally Advanced Cervical Cancer (GIA 13026)
Status: Enrolling
Updated:  12/14/2016
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer
A Phase I/II Study of Docetaxel as a Radiosensitizer for Locally Advanced Cervical Cancer (GIA 13026)
Status: Enrolling
Updated: 12/14/2016
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
Internet-based System for Cancer Patients to Self-report Toxicity
Pilot Study of STAR, an Internet-based System for Cancer Patients to Self-report Toxicity Symptoms, Performance Status, and Quality of Life
Status: Enrolling
Updated:  1/9/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Internet-based System for Cancer Patients to Self-report Toxicity
Pilot Study of STAR, an Internet-based System for Cancer Patients to Self-report Toxicity Symptoms, Performance Status, and Quality of Life
Status: Enrolling
Updated: 1/9/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic
Phase I Study of Dasatinib in Combination With Ipilimumab for Patients With Advanced Gastrointestinal Stromal Tumor and Other Sarcomas
Status: Enrolling
Updated:  1/9/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic
Phase I Study of Dasatinib in Combination With Ipilimumab for Patients With Advanced Gastrointestinal Stromal Tumor and Other Sarcomas
Status: Enrolling
Updated: 1/9/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Zinc Supplements in Lowering Cadmium Levels in Smokers
Do Dietary Supplements of Zinc Reduce Serum Cadmium Levels in Smokers?
Status: Enrolling
Updated:  1/18/2017
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Zinc Supplements in Lowering Cadmium Levels in Smokers
Do Dietary Supplements of Zinc Reduce Serum Cadmium Levels in Smokers?
Status: Enrolling
Updated: 1/18/2017
Wake Forest University Comprehensive Cancer Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
[18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers
[18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers
Status: Enrolling
Updated:  1/23/2017
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
[18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers
[18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers
Status: Enrolling
Updated: 1/23/2017
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Status: Enrolling
Updated:  2/9/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Status: Enrolling
Updated: 2/9/2017
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated:  3/9/2017
DCSNO Carrollton Medical Center
mi
from
New Orleans, LA
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated: 3/9/2017
DCSNO Carrollton Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated:  3/9/2017
DCSNO St Cecelia Medical Center
mi
from
New Orleans, LA
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated: 3/9/2017
DCSNO St Cecelia Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated:  3/9/2017
EXCELth - Ida Hymel Community Health Center
mi
from
New Orleans, LA
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated: 3/9/2017
EXCELth - Ida Hymel Community Health Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated:  3/9/2017
Tulane Communty Health Center at Covenant House
mi
from
New Orleans, LA
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated: 3/9/2017
Tulane Communty Health Center at Covenant House
mi
from
New Orleans, LA
Click here to add this to my saved trials
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated:  3/9/2017
Tulane Faculty Practice
mi
from
New Orleans, LA
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Using Effective Provider-Patient Communication to Improve Cancer Screening Among Low Literacy Patients
Status: Enrolling
Updated: 3/9/2017
Tulane Faculty Practice
mi
from
New Orleans, LA
Click here to add this to my saved trials
Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix
A Phase III Randomized Study of Pretherapeutic Para-aortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Dispositioned to Definitive Chemoradiotherapy
Status: Enrolling
Updated:  3/21/2017
Lyndon B. Johnson General Hospital
mi
from
Houston, TX
Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix
A Phase III Randomized Study of Pretherapeutic Para-aortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Dispositioned to Definitive Chemoradiotherapy
Status: Enrolling
Updated: 3/21/2017
Lyndon B. Johnson General Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix
A Phase III Randomized Study of Pretherapeutic Para-aortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Dispositioned to Definitive Chemoradiotherapy
Status: Enrolling
Updated:  3/21/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix
A Phase III Randomized Study of Pretherapeutic Para-aortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Dispositioned to Definitive Chemoradiotherapy
Status: Enrolling
Updated: 3/21/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials